| Authors: |
Fernandes LE; Tempus Labs, Chicago, IL., Epstein CG; Tempus Labs, Chicago, IL., Bobe AM; Tempus Labs, Chicago, IL., Bell JSK; Tempus Labs, Chicago, IL., Stumpe MC; Tempus Labs, Chicago, IL., Salazar ME; Tempus Labs, Chicago, IL., Salahudeen AA; Tempus Labs, Chicago, IL., Pe Benito RA; Tempus Labs, Chicago, IL., McCarter C; Tempus Labs, Chicago, IL., Leibowitz BD; Tempus Labs, Chicago, IL., Kase M; Tempus Labs, Chicago, IL., Igartua C; Tempus Labs, Chicago, IL., Huether R; Tempus Labs, Chicago, IL., Hafez A; Tempus Labs, Chicago, IL., Beaubier N; Tempus Labs, Chicago, IL., Axelson MD; Tempus Labs, Chicago, IL., Pegram MD; Stanford Comprehensive Cancer Institute, Stanford University School of Medicine, Stanford, CA., Sammons SL; Department of Medicine, Duke University Medical Center, Duke University, Durham, NC., O'Shaughnessy JA; Baylor University Medical Center, Texas Oncology and US Oncology, Dallas, TX., Palmer GA; Tempus Labs, Chicago, IL. Electronic address: publications@Tempus.com. |